Biotec Pharmacon is a public Norwegian group within the biotechnology sector operating through two active subsidiaries, Biotec BetaGlucans AS and ArcticZymes AS. Biotec BetaGlucans develops and manufactures immune modulating compounds for the human health sectors. The company is spearheading research on products that may prevent or treat diseases caused by failure, imbalance and over-reaction of the immune system. ArcticZymes develops and manufactures heat labile marine enzymes used in molecular biology and diagnostics aiming at OEM customers worldwide. Biotec Pharmacon group is connected to BioTech North, a biotechnology cluster based in Tromsø.